MARKET

IQV

IQV

Iqvia Hldgs Inc
NYSE
229.60
+2.51
+1.11%
Pre Market: 229.60 0 0.00% 09:11 05/28 EDT
OPEN
227.46
PREV CLOSE
227.09
HIGH
229.92
LOW
226.93
VOLUME
15
TURNOVER
0
52 WEEK HIGH
261.73
52 WEEK LOW
167.42
MARKET CAP
41.83B
P/E (TTM)
31.33
1D
5D
1M
3M
1Y
5Y
IQVIA Holdings (IQV) Gets a Buy from Jefferies
TipRanks · 5h ago
IQVIA: Long-Term Compounder Throwing Off Free Cash Flow
IQVIA Holdings Inc. Produced strong Q1 2024 earnings, with growth observed in all segments. IQVIA is in the advanced analytics and clinical research services business. The company's earnings have grown at a strong CAGR of 22% in the last 9 years. IQVA is worth $248 per share in my base case for the company.
Seeking Alpha · 21h ago
Weekly Report: what happened at IQV last week (0520-0524)?
Weekly Report · 1d ago
Here's Why You Should Hold on to IQVIA (IQV) Stock for Now
NASDAQ · 4d ago
Possible Bearish Signals With IQVIA Holdings Insiders Disposing Stock
IQVIA Holdings Inc. Insiders have sold shares in the company over the last year. The company has a high insider ownership of US$340m. Over the last three months IQVIA Holding has seen significant insider selling. But the company doesn't have any insider buying in the last 12 months. It is good to see an insider sale of shares at a lower price, but it's not a good sign for shareholders. IQvIA Holdings isn't the best stock to buy but there are two warning signs you should be aware of. The insider selling of IQVia Holdings shares is slightly below the average for the company's share price.
Simply Wall St · 6d ago
Weekly Report: what happened at IQV last week (0513-0517)?
Weekly Report · 05/20 09:16
Weekly Report: what happened at IQV last week (0506-0510)?
Weekly Report · 05/13 09:16
IQVIA Holdings Announces Executive Team Reshuffle and Role Change
TipRanks · 05/10 20:53
More
About IQV
IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The Company's Connected Intelligence delivers insights enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients. The Company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides mission critical information, technology solutions and real-world insights and services to life science clients. Research & Development Solutions primarily serves biopharmaceutical clients, provides outsourced clinical research and clinical trial services. Contract Sales & Medical Solutions provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market.

Webull offers Iqvia Holdings Inc stock information, including NYSE: IQV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IQV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IQV stock methods without spending real money on the virtual paper trading platform.